NCT00273247 Treatment With IFN After Curative Resection of HCC in HCV-Related Cirrhosis Status COMPLETED Phase PHASE3
NCT00242502 Efficacy and Safety Study of Bevacizumab and Erlotinib to Treat Primary Liver Cancer That Cannot be Removed By Surgery Status COMPLETED Phase PHASE2
NCT00234182 Postoperative Adjuvant Therapy With Recombinant Interferon-Alpha Following Curative Resection of HCC Status COMPLETED Phase PHASE1/PHASE2
NCT00183885 A Phase II Study of Intra-arterial Chemotherapy With Cisplatin and Mitomycin-C in Patients With Hepatocellular Carcinoma Status COMPLETED Phase PHASE2
NCT00168987 Influence of an Oral Nutritional Supplement Rich in Omega-3 Fatty Acids on Functional State and Quality of Life in Malnourished Patients With Gastroenterological Tumors Status COMPLETED Phase PHASE4
NCT00165633 A Phase II/III Clinical Study on Inhibitory Effects of E0167 on Recurrence of Hepatocellular Carcinoma Status TERMINATED Phase PHASE2/PHASE3
NCT00155272 Radiotherapy Plus Thalidomide in Locally Advanced Hepatocellular Carcinoma Status UNKNOWN Phase PHASE1/PHASE2
NCT00154817 A Phase II Study of Radiotherapy for Locally Advanced Hepatocellular Carcinoma (HCC) Status COMPLETED Phase PHASE2
NCT00154531 Identification of Biomarkers Associated With Human Hepatocellular Carcinoma by SELDI Status UNKNOWN Phase N/A
NCT00151671 Effect of a Perioperative Oral Nutritional Supplementation on Patients Undergoing Hepatic Surgery for Liver Cancer Status TERMINATED Phase PHASE2/PHASE3
NCT00149565 Phase Ⅲ Randomized Trial in Postoperative Hepatocellular Carcinoma Status COMPLETED Phase PHASE3
NCT00142467 Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Patients With Hepatocellular Carcinoma Status COMPLETED Phase PHASE2
NCT00142428 Cetuximab in Patients With Unresectable or Metastatic Hepatocellular Carcinoma Status COMPLETED Phase PHASE2
NCT00076609 Study of Botanical PHY906 Plus Capecitabine for Advanced Unresectable Hepatocellular Carcinoma Status COMPLETED Phase PHASE1/PHASE2
NCT00073736 Safety and Tolerability of I.V. Infusion of MB07133 in Patients With Unresectable Hepatocellular Carcinoma Status COMPLETED Phase PHASE1/PHASE2
NCT00059267 Prevention of Recurrent Hepatitis B After Liver Transplantation Status COMPLETED Phase N/A